Interestingly, increased levels of RANTES have been detected in serum (38) and skin lesions (39) of SLE patients, pointing to a role for this chemokine in the inflammatory processes observed in lupus and LPI-related lupus-like syndromes. Here, CCL5 is linked to drug-induced lupus erythematosus.